Matches in Wikidata for { <http://www.wikidata.org/entity/Q94516597> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- Q94516597 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q94516597 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q94516597 description "scientific article published on 30 April 2020" @default.
- Q94516597 description "wetenschappelijk artikel" @default.
- Q94516597 description "наукова стаття, опублікована 30 квітня 2020" @default.
- Q94516597 name "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" @default.
- Q94516597 name "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" @default.
- Q94516597 type Item @default.
- Q94516597 label "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" @default.
- Q94516597 label "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" @default.
- Q94516597 prefLabel "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" @default.
- Q94516597 prefLabel "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" @default.
- Q94516597 P1433 Q94516597-4A82AB39-74BC-4492-8BF8-14DE65705337 @default.
- Q94516597 P1476 Q94516597-3839A7A5-438D-4B75-B377-78069BE9388F @default.
- Q94516597 P2093 Q94516597-2CA14D00-9211-4D89-870B-873EEA798797 @default.
- Q94516597 P2093 Q94516597-2CDC36A5-7D5A-4D67-A11E-11A7F2B1AC4B @default.
- Q94516597 P2093 Q94516597-374E2ADA-EEF0-46E8-99EF-74F7ECEE0709 @default.
- Q94516597 P2093 Q94516597-4A9676A1-40FF-4236-8E1A-0699126D14B2 @default.
- Q94516597 P2093 Q94516597-7BAA756E-B700-4492-AB04-A89DA75AADCC @default.
- Q94516597 P2093 Q94516597-98522D40-A26F-49E5-AE7B-C6BF3E4D9C24 @default.
- Q94516597 P2093 Q94516597-9FB0A2C1-6091-4395-BA3F-8C50CA56BB19 @default.
- Q94516597 P2093 Q94516597-C272147B-6798-4018-8BE3-D8F26B995582 @default.
- Q94516597 P2093 Q94516597-CFE75AD0-8C58-427B-B35E-33C37F7C79DC @default.
- Q94516597 P2093 Q94516597-DD066357-A0BC-401A-B8D4-7A0460BAC1B1 @default.
- Q94516597 P2093 Q94516597-E71AD772-343A-4A21-B54D-F1DF3A4C33DE @default.
- Q94516597 P2093 Q94516597-F66E1595-4B7E-4A63-8DF0-D21B5ED48C43 @default.
- Q94516597 P2093 Q94516597-F95837EB-1735-430A-9908-04C69EDC3713 @default.
- Q94516597 P2093 Q94516597-FA3714E0-DE65-412F-B8A6-14039DE08215 @default.
- Q94516597 P2093 Q94516597-FA8CF35B-C2CD-4584-A1F9-0EF0A5712FCE @default.
- Q94516597 P275 Q94516597-3a11a338-88d3-41ae-88c7-0e17cfbb252f @default.
- Q94516597 P31 Q94516597-661706B7-AE0A-4233-9D04-6EB7BBB04DF5 @default.
- Q94516597 P356 Q94516597-3FF1DF80-497B-4C5E-A452-4E66E44CD23B @default.
- Q94516597 P433 Q94516597-7D268974-642B-4F08-9B10-EEEE29E5D1BF @default.
- Q94516597 P478 Q94516597-08501040-7E2A-49FC-93F4-AD731BCE0707 @default.
- Q94516597 P50 Q94516597-69608A25-4D23-4FCE-90E9-0CEA3B912FC0 @default.
- Q94516597 P50 Q94516597-80F18643-AB0F-4DEC-A6F5-DE0A6D27DAA0 @default.
- Q94516597 P50 Q94516597-BA5AD0DA-D64A-4CB2-B6BC-2F0ECE93EAF0 @default.
- Q94516597 P577 Q94516597-BE48627C-5E2F-41A7-AB7C-63B6B1A8E7CA @default.
- Q94516597 P6216 Q94516597-be30f732-5e30-4e5f-9732-8b922353dc7b @default.
- Q94516597 P698 Q94516597-C0740050-122F-452D-BAF8-CCCBC06F80E7 @default.
- Q94516597 P932 Q94516597-716B84DB-5AFC-49DB-BDEC-4F0EECB0F7DC @default.
- Q94516597 P356 CANCERS12051128 @default.
- Q94516597 P698 32365979 @default.
- Q94516597 P1433 Q27722963 @default.
- Q94516597 P1476 "CUL4A, ERCC5, and ERCC1 as Predictive Factors for Trabectedin Efficacy in Advanced Soft Tissue Sarcomas (STS): A Spanish Group for Sarcoma Research (GEIS) Study" @default.
- Q94516597 P2093 "Angela Gavilan-Naranjo" @default.
- Q94516597 P2093 "Antonio Fernandez-Serra" @default.
- Q94516597 P2093 "Antonio Gutierrez" @default.
- Q94516597 P2093 "Elena Blanco-Alcaina" @default.
- Q94516597 P2093 "Javier Martin-Broto" @default.
- Q94516597 P2093 "José L Mondaza-Hernandez" @default.
- Q94516597 P2093 "María Lopez-Alvarez" @default.
- Q94516597 P2093 "Miguel Taron" @default.
- Q94516597 P2093 "Nadia Hindi" @default.
- Q94516597 P2093 "Paloma Sanchez-Bustos" @default.
- Q94516597 P2093 "Paloma Santos-Fernandez" @default.
- Q94516597 P2093 "Paula Martinez-Delgado" @default.
- Q94516597 P2093 "Rafael Ramos" @default.
- Q94516597 P2093 "Samuel Hidalgo-Rios" @default.
- Q94516597 P2093 "Serena Lacerenza" @default.
- Q94516597 P275 Q20007257 @default.
- Q94516597 P31 Q13442814 @default.
- Q94516597 P356 "10.3390/CANCERS12051128" @default.
- Q94516597 P433 "5" @default.
- Q94516597 P478 "12" @default.
- Q94516597 P50 Q88508086 @default.
- Q94516597 P50 Q91620754 @default.
- Q94516597 P50 Q94516595 @default.
- Q94516597 P577 "2020-04-30T00:00:00Z" @default.
- Q94516597 P6216 Q50423863 @default.
- Q94516597 P698 "32365979" @default.
- Q94516597 P932 "7281106" @default.